To further elucidate the role of USP28 in modulating the sensitivity of ovarian cancer cells to olaparib, we constructed lentivirus-infected ovarian cancer cells with either USP28 knockdown or overexpression, followed by treatment with gradient concentrations of olaparib (Fig. 5A). This evidence concerns the gene USP28 and ovarian carcinoma.